Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes

被引：79

作者：

Freemantle, N

Blonde, L

Duhot, D

Hompesch, M

Eggertsen, R

Hobbs, FDR

Martinez, L

Ross, S

Bolinder, B

Stridde, E

机构：

[1] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England

[2] Alton Ochsner Med Fdn & Ochsner Clin, New Orleans, LA 70121 USA

[3] Soc Francaise Med Gen, Issy Les Moulineaux, France

[4] Profil Inst Clin Res, Chula Vista, CA USA

[5] Gothenburg Univ, Dept Primary Hlth Care, Gothenburg, Sweden

[6] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada

[7] Aventis Pharma, Bridgewater, NJ USA

[8] Pfizer, Karlsruhe, Germany

来源：

关键词：

D O I：

10.2337/diacare.28.2.427

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：427 / 428

页数：2

共 8 条

[1] Bélanger A, 2002, DIABETOLOGIA, V45, pA260
[2] Inhaled human insulin treatment in patients with type 2 diabetes mellitus
Cefalu, WT
Skyler, JS
Kourides, IA
Landschulz, WH
Balagtas, CC
Cheng, SL
Gelfand, RA
[J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (03) : 203 - 207
[3] Cefalu WT, 2002, DIABETOLOGIA, V45, pA260
[4] Heinemann L, 1997, DIABETIC MED, V14, P63, DOI 10.1002/(SICI)1096-9136(199701)14:1<63::AID-DIA298>3.0.CO
[5] 2-F
[6] Klonoff D C, 1999, Diabetes Technol Ther, V1, P307, DOI 10.1089/152091599317224
[7] Quattrin T, 2002, DIABETOLOGIA, V45, pA261
[8] Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
Skyler, JS
Cefalu, WT
Kourides, IA
Landschulz, WH
Balagtas, CC
Cheng, SL
Gelfand, RA
[J]. LANCET, 2001, 357 (9253) : 331 - 335